Sign In

Communications of the ACM

ACM Opinion

Crispr: A Path Through the Thicket

View as: Print Mobile App Share:

Human embryos are prime targets for genome editing.

Credit: L. Souci/BSIP/SPL

The ease of use, accuracy and efficiency of the genome-editing tool CRISPR/Cas9 has led to its broad adoption in research, as well as to preliminary applications in agriculture and in gene therapies involving non-reproductive (somatic) cells.

From Nature
View Full Article



No entries found

Sign In for Full Access
» Forgot Password? » Create an ACM Web Account